Download our Guide for Applicants here. The Consortium has opened a new Request for Proposals (RfP), as it seeks to recruit the following: groups with disease-specific models of vaccine impact for: malaria COVID-19 meningitis A / multivalent meningococcal conjugate vaccine (MMCV) hepatitis B other cross-cutting groups that will add value... [Read More]

The Vaccine Impact Modelling Consortium is delighted to have secured renewed funding of £12.8 million (USD $15.4 million) for the next five years, for a new phase of the project. Funding comes from the Bill & Melinda Gates Foundation; Gavi, the Vaccine Alliance; and the Wellcome Trust. This new phase... [Read More]

The Vaccine Impact Modelling Consortium (VIMC) and the University of Cambridge are running an intensive 6-day short course on Mathematical Modelling for Vaccine-preventable Diseases for participants from low and middle-income countries. The programme combines lectures, discussions and seminars with a series of in-depth practical sessions that help to facilitate understanding... [Read More]

This is the headline finding of our second Consortium-wide vaccine impact estimates, now published in eLife. Read more about the findings in this news feature. Read the full open-access article in eLife: ‘Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world’. Try out our interactive... [Read More]

Imperial College London is recruiting two Research Associates/Fellows for the Vaccine Impact Modelling Consortium. The closing date is 28 April 2021. [Read More]